dopamine vs dobutamine in cardiogenic shock


So if you are worried about Dopamine vs Dobutamine . Crit Care Med. Design: Open, randomized interventional human study. It’s used in heart failure and cardiogenic shock. The effects of dopamine, dobutamine and amrinone on mitochondrial function in cardiogenic shock. Patients: Thirty patients with a cardiac index of <2.2 L/min−1/m−2 and a mean arterial pressure of <60 mm Hg resistant to combined dopamine-dobutamine treatment and signs of shock. . Pump you up This was a multi-center RCT of 1679 patients with mixed forms of shock requiring pressors who were treated with either norepinephrine vs. dopamine. Shock. In pursuit of evidence-based rationales for my hatred of dopamine, I turned to PubMed and queried the database for “dopamine shock” filtered for meta-analyses, randomized controlled trials, and systematic reviews in adult patients since 2009. Dopamine is widely used to increase blood pressure, cardiac output, urine output and peripheral perfusion in neonates with shock and cardiac failure. Adult patients with cardiogenic shock regardless of etiology who received initial inotrope therapy with either milrinone (n = 50) or dobutamine (n = 50) and did not receive mechanical circulatory support were included. 167 patients were admitted in the Cardiovascular Intensive Care Unit of our Hospital with a diagnosis of SC between March 2012-August 2017. Podcast 10 – Cardiogenic Shock. Dopamine In Shock And Kidney Injury. Even more importantly, they found a higher overall 28-day mortality in the subgroup of patients with cardiogenic shock who were treated with dopamine. Dopamine and dobutamine are both substances that have important actions on our bodies 3. Vasopressors and inotropes are routinely used in acute myocardial infarction (AMI) related cardiogenic shock (CS) to improve hemodynamics. Electron microscopy revealed mitochondrial damage in the Saline group only. we’ve got you covered. The AHA formerly recommended dopamine first line for cardiogenic shock. Dobutamine (sympathomimetic agent) is a beta1-receptor agonist, though it has some beta2-receptor and minimal alpha-receptor activity. resistant cardiogenic shock. A systematic search of MEDLINE, EMBASE and CENTRAL was performed up to 20 February 2019. • Symptoms and signs : Oliguria, decreased mental status, decrease peripheral pulses and diaphoresis. CS is caused by severe impairment of myocardial performance that results in diminished cardiac output, end‐organ hypoperfusion, and hypoxia. The dopamine-dobutamine combination increased mean arterial pressure (p less than 0.05 vs dobutamine), maintained pulmonary capillary wedge pressure within normal limits (p less than vs dopamine), and prevented the worsening of hypoxemia induced by dopamine (p less than 0.05). Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. However, significantly more patients in the dopamine group than in the norepinephrine group experienced arrhythmias (24% vs. 12%). Dopamine is typically used in the treatment of septic shock or cardiogenic shock. Cardiogenic shock (CS) is a common cause of mortality, and management remains challenging despite advances in therapeutic options. Now norepinephrine is recommended first line in patient with undifferentiated shock (Surviving Sepsis 2016). It may also be used in certain types of cardiac stress tests. The amount of medication needs to be adjusted to the desired effect. Both drugs increase cardiac index but heart rate also rises, and the increase in stroke index is relatively small. Rishi March 7, 2020. Setting: Medical intensive care unit in a university hospital. (less than 10mcg/kg/min because more than that causes major alpha 1 activation which increases SVR which is contraindicated in cardiogenic shock bc increased SVR increases afterload) Mohamed, a listener from Sudan, emailed asking about the treatment of acute pulmonary edema in patients with low blood pressure. The dopamine-dobutamine combination appears to be useful in the management of mechanically … Dobutamine and salbutamol have closely similar haemodynamic effects when used in cardiogenic shock after acute myocardial infarction. The primary end point was the time to resolution of cardiogenic shock. Now I know that dopamine increases myocardial oxygen demand, but it seems that dopamine is still widely used for hypotensive MI pts. Norepinephrine is well established as first-line vasopressor for septic shock ( Dellinger 2013 ), and mounting evidence shows n orepinephrine should be the default pressor for most shock syndromes, including cardiogenic shock ( Gamper et … Changes in hemodynamic parameters from baseline and adverse events were also assessed. Onset of effects is generally seen within 2 minutes. Dobutamine and salbutamol have closely similar haemodynamic effects when used in cardiogenic shock after acute myocardial infarction. And, dobutamine, on the other hand, is generally given to increase cardiac output and it s used in heart failure and cardiogenic shock. On our fire engines, it's the only pressor that we carry, so sometimes you have to do what you have to do to keep the BP up. placebo vs dopamine vs dobutamine-> increased U/O with dopamine but no change in CrCl-> improved CrCl while no change in U/O with dobutamine compared with placebo -> increased urine output is not synonymous with improved renal function; ANZICS (2000, Lancet) RCT – dopamine vs placebo; no change in Cr, ICU LOS, hospital LOS, RRT-> don’t use low dose dopamine for renal … This is in distinction to SCAPE patients (see podcast 1 ). Sensibly, placebo-controlled data for inotropes in cardiogenic shock is lacking. Dobutamine in cardiogenic shock. For the main safety endpoint, the observed higher incidence of refractory shock in the epinephrine group (10 of 27 [37%] vs. norepinephrine 2 of 30 [7%]; p = 0.008) led to early termination of the study. Drug of choice for ↑ CO as it does not cause ↑ HR at lower doses leading to less myocardial oxygen demand. ... the squeeze to help counter that effect of septic shock. Mean arterial pressure is altered little by either agent, but dobutamine (in contrast with dopamine) tends to reduce pulmonary artery end … Because these doses, it will lead to less myocardial oxygen demand, so that s great in heart failure and cardiogenic shock. Cardiogenic shock, a pre-specified subgroup, showed higher 28-day mortality with dopamine (p=0.03) Dopamine group required more open-label norepinephrine (26% vs. 20%, p<0.001), had higher urine output in first 24 hours (but similar overall fluid balance), and had a higher heart rate Both drugs increase cardiac index but heart rate also rises, and the increase in stroke index is relatively small. The impairment of mitochondrial in non-infarcted myocardium under cardiogenic shock … ; Epinephrine: Viable alternative as increases cardiac contractility and blood pressure but also exacerbates myocardial oxygen demand. A flight nurse that I know was recently reemed by an ER doc for starting an MI pt in cardiogenic shock on dopamine. It is given by injection into a vein or intraosseous as a continuous infusion. Cardiogenic shock is typically treated with dobutamine (cardiogenic shock is a pump problem remember) and if BP support is needed since dobutamine doesnt really increase BP, typically dopamine is added. Dobutamine (beta-1/2 agonist activity) – may augment cardiac output but also causes vasodilation and may lead to a significant BP drop Norepinephrine: Superior to dopamine in undifferentiated shock and in subgroup with cardiogenic shock (De Backer 2010). For the primary efficacy endpoint, cardiac index evolution was similar between the two groups (p = 0.43) from baseline (H0) to H72. Cardiogenic shock (CS) is a clinical condition of inadequate tissue(end organ) perfusion due to cardiac dysfunction • Hypotension (SBP < 80-90 mmHg) or MAP 30 mmHg below baseline • Reduced cardiac index(<1.8 L/min per m2) <2.0-2.2 L/min per m2 with support • Adequate or elevated filling pressures. . in HF and Cardiogenic shock. Dobutamine and salbutamol have closely similar haemodynamic effects when used in cardiogenic shock after acute myocardial infarction. However, in the Dopamine, Dobutamine, and Amrinone groups, the mitochondria functioned at a higher level. September 16, 2009 by Scott Weingart, MD FCCM 22 Comments. • Clinical hypotension is usually found, i.e., mean arterial pressure <60 mmHg or systolic blood pressure < 90 mmHg in previously normotensive persons. Dobutamine is a drug that acts on the sympathetic nervous system. 2011;39(3):450–5. We aimed to investigate the effect of routinely used vasopressor and inotropes on mortality in AMI related CS. A prospective, randomized pilot study. However, its action in potassium channels of the smooth muscle produces vasodilation and it makes its use in cardiogenic shock (CS) controversial. 2 2 minutes read. The current opinion in critical care seems to be that dobutamine and levosimendan are equally highly regarded in this setting, attracting a class IIa recommendation. Shock evaluation protocol Shock definition • Shock is the clinical syndrome that results from inadequate tissue perfusion. 2014;41(4):269–74; Levy B, Perez P, Perny J, Thivilier C, Gerard A. Dobutamine is a medication used in the treatment of cardiogenic shock and severe heart failure. Dobutamine is generally given to increase cardiac output. Physicians use it to treat heart failure and cardiogenic shock. Mukae S(1), Yanagishita T, Geshi E, Umetsu K, Tomita M, Itoh S, Konno N, Katagiri T. Author information: (1)Third Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan. In eight mechanically ventilated patients in cardiogenic shock, we assessed the hemodynamic effects of an infusion of dopamine and dobutamine and evaluated its role in preventing the deleterious effects of administering each amine alone. Both act at specific cell receptors and produce significant changes in those cells. Okay.